Blog
About

36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

      The Journal of clinical investigation

      Animals, Angiography, Apoptosis, drug effects, Aspartic Acid, analogs & derivatives, pharmacology, Caspase 3, Caspase Inhibitors, Caspases, metabolism, Cell Adhesion, Cells, Cultured, Collagen, DNA Fragmentation, Dose-Response Relationship, Drug, Drug Combinations, Enzyme Inhibitors, Epithelial Cells, cytology, Immunohistochemistry, In Situ Nick-End Labeling, Indoles, Laminin, Lung, chemistry, pathology, Male, Proliferating Cell Nuclear Antigen, Protease Inhibitors, Proteoglycans, Pulmonary Emphysema, etiology, radiography, Pyrroles, Rats, Rats, Sprague-Dawley, Receptor Protein-Tyrosine Kinases, antagonists & inhibitors, Receptors, Growth Factor, Receptors, Vascular Endothelial Growth Factor

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pulmonary emphysema, a significant global health problem, is characterized by a loss of alveolar structures. Because VEGF is a trophic factor required for the survival of endothelial cells and is abundantly expressed in the lung, we hypothesized that chronic blockade of VEGF receptors could induce alveolar cell apoptosis and emphysema. Chronic treatment of rats with the VEGF receptor blocker SU5416 led to enlargement of the air spaces, indicative of emphysema. The VEGF receptor inhibitor SU5416 induced alveolar septal cell apoptosis but did not inhibit lung cell proliferation. Viewed by angiography, SU5416-treated rat lungs showed a pruning of the pulmonary arterial tree, although we observed no lung infiltration by inflammatory cells or fibrosis. SU5416 treatment led to a decrease in lung expression of VEGF receptor 2 (VEGFR-2), phosphorylated VEGFR-2, and Akt-1 in the complex with VEGFR-2. Treatment with the caspase inhibitor Z-Asp-CH(2)-DCB prevented SU5416-induced septal cell apoptosis and emphysema development. These findings suggest that VEGF receptor signaling is required for maintenance of the alveolar structures and, further, that alveolar septal cell apoptosis contributes to the pathogenesis of emphysema.

          Related collections

          Author and article information

          Journal
          11104784
          387249
          10.1172/JCI10259

          Comments

          Comment on this article